The Treatment and Natural History of Acromegaly - Full Text View

Purpose

The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to acromegaly.

Condition
Acromegaly Pituitary Neoplasm

Study Type:	Observational
Official Title:	Acromegaly Treatment and Natural History

Resource links provided by NLM:

MedlinePlus related topics: Cancer Pituitary Tumors

U.S. FDA Resources

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:	99999999
Study Start Date:	April 1985

Detailed Description:

The purpose of this study is to investigate the treatment and natural history of acromegaly. We have a longstanding interest in acromegaly treatment, and a cohort that has been followed for 30 years, or more in some cases. We will continue to follow patients and recruit new patients for treatment and follow-up.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

INCLUSION CRITERIA:

Patients will be enrolled who are 18 years of age or over who are referred for care.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001981

Contacts

Contact: Craig S Cochran, R.N.	(301) 402-1880	craigc@bdg10.niddk.nih.gov
Contact: Phillip Gorden, M.D.	(301) 402-7340	gordenp@extra.niddk.nih.gov

Locations

United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike	Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

Principal Investigator:

Phillip Gorden, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

More Information

Additional Information:

NIH Clinical Center Detailed Web Page This link exits the ClinicalTrials.gov site

Publications:

Eastman RC, Gorden P, Glatstein E, Roth J. Radiation therapy of acromegaly. Endocrinol Metab Clin North Am. 1992 Sep;21(3):693-712. Review.

Gorden P, Comi RJ, Maton PN, Go VL. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med. 1989 Jan 1;110(1):35-50. Review.

Eastman RC, Arakaki RF, Shawker T, Schock R, Roach P, Comi RJ, Gorden P. A prospective examination of octreotide-induced gall-bladder changes in acromegaly. Clin Endocrinol (Oxf). 1992 Mar;36(3):265-9.

ClinicalTrials.gov Identifier:	NCT00001981 History of Changes
Other Study ID Numbers:	850082, 85-DK-0082
Study First Received:	January 21, 2000
Last Updated:	May 1, 2013
Health Authority:	United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Somatostatin Analogue
Acromegaly
TSH Producing Tumor
Islet Cell Tumor

Ursodeoxycholate
Pituitary
Irradiation
Treatment

Additional relevant MeSH terms:

Acromegaly
Neoplasms
Pituitary Neoplasms
Bone Diseases, Endocrine
Bone Diseases
Musculoskeletal Diseases
Hyperpituitarism
Pituitary Diseases
Hypothalamic Diseases
Brain Diseases

Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms

ClinicalTrials.gov processed this record on May 16, 2013